Home   Kent Business   County News   Article

University of Greenwich in Medway receives €200,000 from German pharmaceutical company Merck Consumer Health Care to develop pain relief drugs

17 June 2014
by Chris Price

Research teams at a university have been given €200,000 (£159,500) from a German pharmaceutical firm to develop two pain relief drugs.

The team at Medway Centre for Pharmaceutical Sciences at the University of Greenwich will make non-steroid injections with added B-vitamins in the deal with Merck Consumer Health Care.

They plan to use the drugs in Latin America, once the Medway team has made the ingredients inside the medicine stable and effective in different climates.

A health care company is investing money into Kent research

A health care company is investing money into Kent research

Their research is being continued at a manufacturing site run by Merck in Mexico, where the Greenwich injections will be produced and tested.

The Medway team will also develop a pain-relieving skin cream for the German firm.

Professor John Mitchell said: “We are delighted Merck Consumer Health Care is now one of the growing number of international companies taking advantage of the expertise and research facilities at the Medway Centre for Pharmaceutical Sciences.

“We will be looking to work with even more pharmaceuticals companies from home and abroad following the expansion of our team.”

Details at

Click here for more news from Kent Business.

Click here for more news from around the county.


Forgotten Password?

Forgotten Username?

Don't have an account? Please Register first!

The KM Group does not moderate comments.
Please click here for our house rules.

Thank you. Your comment has been received and will appear on the site shortly.


Terms of Comments
We do not actively moderate, monitor or edit contributions to the reader comments but we may intervene and take such action as we think necessary, please click here for our house rules.. If you have any concerns over the contents on our site, please either register those concerns using the report abuse button, contact us here, email or call 01634 227989.